Skip to main content
OpenTrials
Completed

NCT Number: NCT05471284

Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jordan Neil

Oklahoma City, Oklahoma, 73104, United States

About this study

Background: A cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials offer cessation resources but have low accrual rates. Digital outreach may improve accrual, but knowledge of how best to recruit smokers with recent diagnoses is limited.

Objective: This study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer.

Methods: From February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Speak and understand English
  • A recent cancer diagnosis (within the past 24 months)
  • 18 years or older
  • Report any cigarette use within the past 30 days

Exclusion criteria

  • Do not speak or understand English
  • Have not been diagnosed with cancer within the past 24 months
  • Below the age of 18
  • Does not report any cigarette use within the past 30 days

Treatment and study plan

Proximal

Behavioral

The first factor tested framing of the near, proximal threat of continued smoking.

Distal

Behavioral

The first factor tested framing of the long-term, distal threat of continued smoking.

Cost

Behavioral

Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.

Benefit

Behavioral

Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.

Loss

Behavioral

The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.

Gain

Behavioral

The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.

Control

Behavioral

Does not include any of the three message factors.

Primary outcomes

  1. Difference in intent to talk to a physician about participating in a smoking cessation study between factors.

    Time frame: Within 30 minutes

    The main effect within each message factor level was examined using ANOVA and compared with the control condition.

Secondary outcomes

  1. Predictors of intent to talk to a physician about participating in a smoking cessation study.

    Time frame: Within 30 minutes

    Other message evaluation and effectiveness measures were collected and explored in a multivariable model predicting intent to talk to a physician.

Sponsors and collaborators

Lead sponsor

University of Oklahoma

Other

Collaborators

  • Massachusetts General Hospital
  • Memorial Sloan Kettering Cancer Center
  • Tufts University

Registry information

Official study title

A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jul 22, 2022
Registry last updated
Jul 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.